Dr. Shore on Stem Cell Transplant in Ethnic Populations

Tsiporah B. Shore, MD
Published: Tuesday, May 09, 2017



Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program of Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies.

Stem cell transplant is a very important procedure that should be available for all patients, Shore explains. However, for those who are in multi-ethnic populations, physicians should accommodate many groups of patients. There are very limited donors for these patient populations, but something must be done to allow patients to have this therapeutic option.

Additionally, a new method is the haplo-cord transplant and haploidentical transplant, which largely help to find transplants for a wider variety of patients.


Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program of Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies.

Stem cell transplant is a very important procedure that should be available for all patients, Shore explains. However, for those who are in multi-ethnic populations, physicians should accommodate many groups of patients. There are very limited donors for these patient populations, but something must be done to allow patients to have this therapeutic option.

Additionally, a new method is the haplo-cord transplant and haploidentical transplant, which largely help to find transplants for a wider variety of patients.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Year in Review™: Reflecting on Recent Evidence for the Treatment of Hematologic MalignanciesFeb 28, 20192.0
Publication Bottom Border
Border Publication
x